GLP-1 boom causing pharma FOMO
US$ 22.68
semaglutide commercial #Ad Check out Med Guide & Safety: @ozempicmedguide New jingle alert! John and I got back together in partnership with Novo Nordisk and worked with world-class jingleologists to create our own (and #commercial #tgegreatestshowman #wegovy | TikTok
Description
GIP receptor adaptation follows a similar timeline
This reasoning is understandable, but medically risky
Cahill said it is a phase two study to provide proof of concept
Current performance may be lower or higher than the performance data quoted
Moreover, its design resists enzymatic breakdown
